Here's the Deal
Baird's Investment Banking Group is pleased to announce the following transaction:
Sale of Kforce Clinical Research, Inc. to inVentiv Health, Inc.
Baird served as the exclusive financial advisor to Kforce Inc.
Kforce Inc. (NASDAQ-GS: KFRC) (“Kforce” or the “Company”) completed the sale of its wholly owned subsidiary, Kforce Clinical Research, Inc. (“KCR”), to inVentiv Health, Inc. (“inVentiv”).
Kforce is a professional staffing and solutions firm providing flexible and permanent staffing solutions in the skill areas of technology, finance & accounting, and health and life sciences. Kforce has over 2,200 associates and approximately 11,000 consultants on assignment. The Company operates from 63 offices located throughout the United States and one in the Philippines. KCR is a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies. KCR will be combined with inVentiv’s existing functional service provider and staffing businesses within its Clinical segment. Kforce is headquartered in Tampa, Florida.
inVentiv is a global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. inVentiv has 13,000 employees in 40 countries and is privately owned by inVentiv Group Holdings Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team.